N - alkyl 2 - (1 - (5 - (2 - (3 - (3 - oxo - trifluorometilsulfonamido) propyl) benzyl) pyrrolidin-2-one IL - 4 - carboxamide) oxazole and its use in preparing a Medicament used for treating diseases or conditions mediated by receptor DP, FP, EP, EP PD, PT and / or
Composed of N - alkyl 2 - (1 - (5 - (2 - (3 - (3 - oxo - trifluorometilsulfonamido) propyl) benzyl) pyrrolidin-2-one IL - 4 - carboxamide) oxazole Substituent, where 5 is selected from the group consisting of Radical and alkyl radical Halo alquiloxi, that is a radical N - alkyl or cycloalkyl and told lies L N - alkyl comprises 5 to 10 carbon Atoms.Use for preparing Medicine useful for treating diseases or conditions mediated by DP1 receptor, EP3, FP, EP1, TP and / or EP4.Compuesto de N-alquil-2-(1-(5-sustituido-2-(3-oxo-3-(trifluorometilsulfonamido)propil)bencil)pirrolidin-2-il)oxazol-4-carboxamida, donde el sustituyente 5 se selecciona entre el grupo formado por radicales halo y alquiloxi, dicho radical alquilo es un radical n-alquilo o cicloalquilo y dicho radical n-alquilo comprende de 5 a 10 átomos de carbono. Uso para preparar un medicamento útil para tratar enfermedades o afecciones mediadas por receptor DP1, FP, EP1, EP3, TP y/o EP4.
